FDA (Drugs) recall action 72294
The FDA (Drugs) publishes a recall like this one as 2 separate product records. They share a firm, a date and a cause; this page is all of them in one place, so the scale of the action is visible rather than spread across 2 pages.
Marketed without an Approved NDA/ANDA: Products contain undeclared desmethyl carbondenafil and dapoxetine.
The agency’s own wording, quoted from the enforcement report.
The unit total adds up the quantities the agency stated for each product. Where a product record gave no figure, or gave a weight rather than a count, it contributes nothing — so the real total is at least this, never less.
Tf Supplements is recalling Rhino 7 Platinum 3000 because it contains undeclared desmethyl carbondenafil and dapoxetine and was marketed without an approved NDA or ANDA.
Tf Supplements is recalling Rhino 7 3000 bottles because they contain undeclared desmethyl carbondenafil and dapoxetine and were marketed without an approved NDA or ANDA.